Tech Company Financing Transactions
Ventaira Pharmaceuticals Funding Round
TL Ventures and private investors invested in a $1.9 million funding round for Ventaira Pharmaceuticals. The funding round was announced by the company on 9/30/2007.
Transaction Overview
Company Name
Announced On
9/30/2007
Transaction Type
Venture Equity
Amount
$1,942,000
Round
Undisclosed
Investors
TL Ventures (Devang Kantesaria)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1801 Watermark Drive 100
Columbus, OH 43215
USA
Columbus, OH 43215
USA
Phone
Website
Email Address
Not Recorded
Overview
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary ele ctrohydrodynamic (EHD) aerosolization and formulation technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leslie Williams
Chief Financial Officer
Janice Beauchamp
VP - Product Management
John Denny
VP - R & D
Lex Adjei
Browse more venture capital transactions:
Prev: 9/30/2007: WideOrbit venture capital transaction
Next: 9/30/2007: Elixir Pharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs